Showing results (51-60 of 206) with videos related to
Sort By:
Pageof 21
International Journal of Pharmaceutics|February 7, 2012
In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injuryJason C Stanwick, M Douglas Baumann, Molly S ShoichetBiomedical Materials (Bristol, England)|March 30, 2012
Injectable hydrogels for central nervous system therapyMalgosia M Pakulska, Brian G Ballios, Molly S ShoichetBiomaterials Science|July 28, 2015
Sustained delivery of bioactive neurotrophin-3 to the injured spinal cordIrja Elliott Donaghue, Charles H Tator, Molly S ShoichetAccounts of Chemical Research|March 28, 2017
Engineering Cellular Microenvironments with Photo- and Enzymatically Responsive Hydrogels: Toward Biomimetic 3D Cell Culture ModelsRoger Y Tam, Laura J Smith, Molly S ShoichetJournal of Biomedical Materials Research. Part A|January 11, 2003
Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitroJeffrey M Karp, Molly S Shoichet, John E DaviesBiomaterials|July 19, 2005
Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applicationsStéphane G Lévesque, Ryan M Lim, Molly S ShoichetJournal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2012
Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogelJason C Stanwick, M Douglas Baumann, Molly S ShoichetBrain Research Bulletin|March 23, 2019
A hyaluronan/methylcellulose-based hydrogel for local cell and biomolecule delivery to the central nervous systemMargaret T Ho, Carter J Teal, Molly S ShoichetJournal of Biomedical Materials Research. Part A|February 14, 2007
Peptide surface modification of methacrylamide chitosan for neural tissue engineering applicationsLaura M Y Yu, Karineh Kazazian, Molly S ShoichetJournal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2010
Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery systemCatherine E Kang, Charles H Tator, Molly S ShoichetPageof 21